Results 41 to 50 of about 19,767 (298)

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy

Indian Journal of Endocrinology and Metabolism, 2011
Management of prolactinoma in pregnancy is a big challenge for the treating obstetrician as prolactin levels are normally raised in pregnancy and this creates a possibility of missing the diagnosis of prolactinoma.
Sukhwinder Kaur Bajwa, Sukhminder Jit Singh Bajwa, Praveen Mohan, Anita Singh   +3 more
doaj   +1 more source

The value of PRL in predicting prolactinοma in hyperprolactinemic PCOS [PDF]

, 2018
Background To identify a serum prolactin (PRL) cut‐off value indicative of a PRL‐producing adenoma in women with Polycystic Ovarian Syndrome (PCOS) and hyperprolactinemia and characterize such patients.
Angelousi, Anna, Dimitriadis, Georgios K., Kaltsas, Gregory, Kyritsi, Eleni Magdalini, Mehta, Hiten, Mytilinaiou, Maria, Randeva, Harpal S., Shad, Amjad   +7 more
core   +1 more source

Prolactinoma presenting as chronic anaemia with osteoporosis: a case report

Journal of Medical Case Reports, 2010
Introduction Unexplained anaemia is a rare mode of presentation for prolactinoma. We describe a case of a man, with chronic anaemia ascribed to old age.
Hanley John P, MacLean Fergus R
doaj   +1 more source

Co-Morbidity of Pituitary Adenoma and Frontal Convexity Meningioma: A Case Report and Review of the Literature

International Clinical Neuroscience Journal, 2020
Instruction: The current study reports a woman with pituitary adenoma and frontal convexity meningioma that was detected accidentally. To the best of our knowledge, this case is considered as a rare clinical scenario.
Thi Phuong Hoai Dinh, Dang Thi Mai, Van Tri Truong   +2 more
doaj   +1 more source

Change in Insulin Sensitivity and Lipid Profile After Dopamine Agonist Therapy in Patients With Prolactinoma

Cureus, 2021
Background Prolactinomas are prolactin(PRL)-secreting neoplastic lesions that can lead to metabolic disturbances and insulin resistance. We aimed to find the change in insulin sensitivity and lipid profile in prolactinoma patients after dopamine therapy.
Ghayyur Khalil, F. A. Khan, Q. Jamal, A. Saleem, H. Masroor, K. Abbas   +5 more
semanticscholar   +1 more source

Menstrual cycle abnormalities in patients with prolactinoma and drug-induced hyperprolactinemia

Indian Journal of Endocrinology and Metabolism, 2017
Background and Objective: Hyperprolactinemia affects the reproductive endocrine axis; however, the degree of dysfunction may vary depending on etiology.
Bindu Kulshreshtha, Isha Pahuja, Deepak Kothari, Indu Chawla, Neera Sharma, Shikha Gupta, Anuja Mittal   +6 more
doaj   +1 more source

A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas

Indian Journal of Endocrinology and Metabolism, 2021
Cabergoline has long been used in the medical management of prolactin-secreting pituitary adenomas. However, there is contradicting and inadequate evidence on the efficacy of cabergoline in achieving radiological and biochemical remission in prolactinoma.
Rakesh Mishra, Subhas K Konar, Adesh Shrivastava, Pradeep Chouksey, Sumit Raj, Amit Agrawal   +5 more
doaj   +1 more source

A middle cerebral artery ischemic stroke occurring in a child with a large prolactinoma. [PDF]

, 2020
Pituitary adenomas are rare in children, and often present with symptoms of headache, nausea or emesis, visual disturbance, or hormonal hypersecretion.
Amara, Dominic, Clerkin, Patricia, Gupta, Nalin, Oh, Taemin   +3 more
core  

Giant Prolactinomas [PDF]

Neuroendocrinology, 2018
Prolactin-secreting adenomas (prolactinomas) are the most common secreting adenomas of the pituitary. Microprolactinomas (diameter <10 mm) are frequently diagnosed in women, whereas macroprolactinomas (maximum diameter ≥10 mm) are generally seen in men. Most macroprolactinomas measure between 10 and 40 mm.
openaire   +2 more sources

Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis

Journal of Clinical Endocrinology and Metabolism, 2019
Context The improved remission and complication rates of current transsphenoidal surgery warrant reappraisal of the position of surgery as a viable alternative to dopamine agonists in the treatment algorithm of prolactinomas.
A. Z. Najafabadi, Ingrid M. Zandbergen, Friso de Vries, L. H. Broersen, L. H. Broersen, M. E. V. D. A. Marle, A. Pereira, W. Peul, O. Dekkers, W. Furth, N. Biermasz   +10 more
semanticscholar   +1 more source